Cryptococcal meningitis in HIV infected: Experience from a North Indian tertiary center

Neurology India

Volumn 56, Issue 4, 2008, Pages 444-449

  Kumar, Susheel ^a   Wanchu, Ajay ^a   Chakrabarti, Arunaloke ^a   Sharma, Aman ^a   Bambery, Pradeep ^a   Singh, Surjit ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cryptococcal infection; HIV; Immunocompromised; India; Meningitis; Outcome

Indexed keywords

AMPHOTERICIN B; ANTIHISTAMINIC AGENT; EFAVIRENZ; FLUCONAZOLE; FLUCYTOSINE; LAMIVUDINE; NEVIRAPINE; PARACETAMOL; STAVUDINE; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRYPTOCOCCAL MENINGITIS; DISEASE COURSE; DRUG MEGADOSE; EARLY DIAGNOSIS; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; INDIA; MALE; MORTALITY; RECURRENT DISEASE; SENSORY DYSFUNCTION; SIDE EFFECT; TERTIARY HEALTH CARE; TREATMENT RESPONSE; UREA BLOOD LEVEL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 58749088940     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.44823     Document Type: Article

References (29)

1. Simoes EA, Babu GP, John TJ, Nirmala S, Solomon S, Lakshminarayana CS, et al. Evidence for HTLV-3 infection in prostitutes in Tamilnadu (India). Indian J Med Res 1987;85:335-8.
2. National AIDS Control Organization. Ministry of Health and Family Welfare, Government of India: Technical report India HIV estimates-2006.
3. Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis 2003;36:79-85.
4. Sobhani R, Basavaraj A, Gupta A, Bhave AS, Kadam DB, Sangle SA, et al. Mortality & clinical characteristics of hospitalized adult patients with HIV in Pune, India. Indian J Med Res 2007;126:116-21.
5. Kumarasamy N, Vallabhaneni S, Flanigan TP, Mayer KH, Solomon S. Clinical profile of HIV in India. Indian J Med Res 2005;121:377-94.
6. Sharma SK, Kadhiravan T, Banga A, Goyal T, Bhatia I, Saha PK. Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India. BMC Infect Dis 2004;4:52.
7. Bicanic T, Harrison TS: Cryptococcal meningitis. Br Med Bull 2005;72:99-118.
8. Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin North Am 2002;16:837-74.
9. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, et al. Practice guidelines for the management of cryptococcal disease: Infectious Diseases Society of America. Clin Infect Dis 2000;30:710-8.
10. Satishchandra P, Mathew T, Gadre G, Nagarathna S, Chandramukhi A, Mahadevan A, et al. Cryptococcal meningitis: Clinical, diagnostic and therapeutic overviews. Neurol India 2007;55:226-32.
11. Mwaba P, Mwansa J, Chintu C, Pobee J, Scarborough M, Portsmouth S, et al. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J 2001;77:769-73.
12. Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi V, et al. Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96). Indian J Med Res 2000;111:14-23.
13. Khanna N, Chandramuki A, Desai A, Ravi V. Cryptococcal infection of the central nervous system: an analysis of predisposing factors, laboratory findings and outcome in patients from south India with special reference to HIV infection. J Med Microbiol 1996;45:376-9.
14. Kalra SP, Chadha DS, Singh AP, Sanchetee PC, Mohapatra AK. Cryptococcal meningitis in acquired immunodeficiency syndrome. J Assoc Physicians India 1999;47:958-61.
15. Lakshmi V, Sudha T, Teja VD, Umabala P. Prevalence of central nervous system cryptococcosis in human immunodeficiency virus reactive hospitalized patients. Indian J Med Microbiol 2007;25:146-9.
16. Prasad KN, Agarwal J, Nag VL, Verma AK, Dixit AK, Ayyagari A. Cryptococcal infection in patients with clinically diagnosed meningitis in a tertiary care center. Neurol India 2003;51:364-6.
17. Schaars CF, Meintjes GA, Morroni C, Post FA, Maartens G. Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole. BMC Infect Dis 2006;6:118.
18. Kisenge PR, Hawkins AT, Maro VP, McHele JP, Swai NS, Mueller A, et al. Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania. BMC Infect Dis 2007;7:39.
19. Heyderman RS, Gangaidzo IT, Hakim JG, Mielke J, Taziwa A, Musvaire P, et al. Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis 1998;26:284-9.
20. Moosa MY, Coovadia YM. Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings and outcome for human immunodeficiency virus (HIV) -positive and HIV-negative patients. Clin Infect Dis 1997;24:131-4.
21. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 1991;4:770-6.
22. Murdoch DM, Venter WD, Feldman C, Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 2008;22:601-10.
23. Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC Jr, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005;19:399-406.
24. Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006;42:418-27.
25. Van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome: National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med 1997;337:15-21.
26. Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: A randomised trial. Lancet 2004;363:1764-7.
27. Pitisuttithum P, Tansuphasawadikul S, Simpson AJ, Howe PA, White NJ. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B. J Infect 2001;43:226-33.
28. Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis: A study in 111 cases. Ann Intern Med 1974;80:176-81.
29. Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis: The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000;30:47-54.